RKI-1447, a potent ROCK inhibitor with anti-tumor and anti-invasive activities in breast cancer

被引：0
|
作者：
Patel, Ronil A. [1 ]
Forinash, Kara D. [1 ]
Pireddu, Roberta [1 ]
Sun, Ying [1 ]
Martin, Mathew P. [1 ]
Zhu, Jin-Yi [1 ]
Alexander, Brian G. [1 ]
Schonbrunn, Ernst [1 ]
Lawrence, Nicholas J. [1 ]
Sebti, Said M. [1 ]
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/1538-7445.AM2012-2942
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2942
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Cellular mechanisms mediating the anti-invasive properties of the ornithine decarboxylase inhibitor α-difluoromethylornithine (DFMO) in human breast cancer cells
    Andrea Manni
    Sharlene Washington
    David Mauger
    Deborah A. Hackett
    Michael F. Verderame
    Clinical & Experimental Metastasis, 2004, 21 : 461 - 467
  • [32] Anti-tumor activity of the proteasome inhibitor bortezomib in gastric cancer
    Nakata, Wachiko
    Hayakawa, Yoku
    Nakagawa, Hayato
    Sakamoto, Kei
    Kinoshita, Hiroto
    Takahashi, Ryota
    Hirata, Yoshihiro
    Maeda, Shin
    Koike, Kazuhiko
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2011, 39 (06) : 1529 - 1536
  • [33] Anti-Tumor Activity of the Proteasome Inhibitor Bortezomib in Gastric Cancer
    Nakata, Wachiko
    Hayakawa, Yoku
    Nakagawa, Hayato
    Sakamoto, Kei
    Kinoshita, Hiroto
    Takahashi, Ryota
    Hirata, Yoshihiro
    Maeda, Shin
    Koike, Kazuhiko
    GASTROENTEROLOGY, 2011, 140 (05) : S674 - S674
  • [34] Small molecule inhibitors of Rac1 as anti-invasive breast cancer compounds
    Hernandez, Eliud
    Benitez, Yanira
    de la Mota, Alina
    Dharmawardhane, Suranganie
    Vlaar, Cornelis
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 239
  • [35] Potent anti-tumor activity of mTOR kinase inhibitor in combination with anti-angiogenic agents in preclinical models of renal cell cancer
    Wang, Shunyou
    Lan, Lucy
    Janes, Mathew
    Jessen, Katti
    Kessler, Linda
    Kucharski, Jeff
    Guo, Xin Xin
    Staunton, Jocelyn
    Elia, Marikka
    Banerjee, Urmi
    Stewart, Josh
    Dartania, Levan
    Li, Liansheng
    Chan, Katrina
    Martin, Mike
    Ren, Pingda
    Rommei, Christian
    Liu, Yi
    CANCER RESEARCH, 2012, 72
  • [36] Antiangiogenic and anti-invasive activities of the kinase inhibitor sunitinib malate on experimental human glioblastoma in vitro and in vivo
    de Bouard, S.
    Herlin, R.
    Christensen, J. G.
    Lemoisson, E.
    Gauduchon, P.
    Raymond, E.
    Guillamo, J. S.
    EJC SUPPLEMENTS, 2006, 4 (12): : 22 - 22
  • [37] Anti-tumor potential of Hydralazine, a DNMT1 inhibitor, on breast cancer growth and progression
    Patel, Parth B.
    CANCER RESEARCH, 2019, 79 (13)
  • [38] Anti-tumor effects in combination with PARP inhibitor and DNMT inhibitor in ovarian cancer
    Lee, Jeong-Won
    Jeong, Soo Young
    Ryu, Ji Yoon
    Lee, Yoo-Young
    Esun, Paik
    CANCER RESEARCH, 2019, 79 (13)
  • [39] Parity improves anti-tumor immunity in breast cancer patients
    Krause, Anna-Lena
    Schuetz, Florian
    Boudewijns, Marc
    Pritsch, Maria
    Wallwiener, Markus
    Golatta, Michael
    Rom, Joachim
    Heil, Joerg
    Sohn, Christof
    Schneeweiss, Andreas
    Beckhove, Philipp
    Domschke, Christoph
    ONCOTARGET, 2017, 8 (62): : 104981 - 104991
  • [40] ANTI-TUMOR EFFECT OF LIDOCAINE ON VARIOUS BREAST CANCER CELLS
    Chamaraux-Tran, Thien-nga
    Charton, Antoine
    Noll, Eric
    Pottecher, Julien
    Rio, Marie-Christine
    Geny, Bernard
    Mathelin, Carole
    Tomasetto, Catherine
    Diemunsch, Pierre
    ACTA PHYSIOLOGICA, 2015, 214 : 54 - 54
12345